Case number IPR2017-01995
Mylan Pharmaceuticals Inc. et al. v. Horizon Pharma USA, Inc. et al. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Sep 29, 2020 | 82 | board | Denying Petitioners Request for Rehearing of Denial of Refund 37 C.F.R. seC. 42.71 Download |
| Sep 25, 2020 | 81 | board | Download |
| Nov 6, 2019 | 80 | Request for Rehearing of Notice of Denial of Refund Download | |
| Oct 23, 2019 | 79 | Notice of Refund Denial Download | |
| Aug 13, 2019 | 78 | Mylan Refund Request Download | |
| Aug 12, 2019 | 76 | JUDGMENT Terminating the Proceeding Granting Request to Treat Settlement Agreement as Confidential Business Information 35 U.S.C. sec. 317(a); 37 C.F.R. sec. 42.72, 42.74(c) Download | |
| Aug 12, 2019 | 77 | Decision - Denying Dr. Reddy's Request for Rehearing - 37 CFR 42.71 Download | |
| Jul 29, 2019 | 74 | Motion to Terminate Download | |
| Jul 29, 2019 | 75 | Motion to Keep Confidential Download | |
| Apr 26, 2019 | 73 | Petitioners' Request for Rehearing Under ¿¿ 42.71 Download | |
| Mar 28, 2019 | 72 | Denying Patent Owner's Motions to Terminate Download | |
| Mar 27, 2019 | 71 | Termination Decision Document Download | |
| Feb 28, 2019 | 70 | ORDER Adjusting One-Year Pendency Due to Joinder Download | |
| Feb 22, 2019 | 1056 | Notice of Appeal (District Court) Download | |
| Feb 22, 2019 | 1057 | Notice of Appeal (District Court) Download | |
| Feb 22, 2019 | 1058 | Notice of Appeal (District Court) Download | |
| Feb 22, 2019 | 68 | Response to Motion to Terminate Download | |
| Feb 22, 2019 | 69 | Petitioners' Updated Exhibit List Download | |
| Feb 20, 2019 | 67 | Revising the Scheduling Order Download | |
| Feb 11, 2019 | 66 | PATENT OWNERS¿¿¿ MOTION TO TERMINATE Download | |
| Feb 8, 2019 | 2074 | Ex. 2074 Opening Brief Download | |
| Feb 8, 2019 | 2073 | Ex. 2073 Markman Opinion Download | |
| Feb 8, 2019 | 64 | Patent Owners Exhibit List Download | |
| Feb 8, 2019 | 2075 | Ex/ 2075 MSJ Opinion Download | |
| Feb 8, 2019 | 2076 | Ex. 2076 Mylan Judgment Download | |
| Feb 8, 2019 | 65 | Mylan Brief on Click-to-Call Download | |
| Feb 8, 2019 | 2077 | Ex. 2077 DRL Judgment Download | |
| Feb 8, 2019 | 63 | PATENT OWNERS¿¿¿ BRIEFING REGARDING CLICK-TO-CALL TECHS., L.P. v. INGENIO, INC. Download | |
| Feb 8, 2019 | 2072 | Ex. 2072 2016-03-31 Plfs' Disclosure of Asserted Claims to Mylan Download | |
| Jan 31, 2019 | 62 | Proposed Scheduling Order Download | |
| Jan 28, 2019 | 61 | Order - Granting Unopposed Motion to Withdraw Counsel - 37 CFR 42.10 Download | |
| Jan 25, 2019 | 60 | ORDER - Conduct of the Proceeding 37 .C.F.R ¿¿ 42.5 Download | |
| Jan 25, 2019 | 59 | ORDER - Conduct of the Proceeding 37 .C.F.R ¿¿ 42.5 Download | |
| Jan 24, 2019 | 58 | PETITIONER¿¿¿S MOTION FOR WITHDRAWAL OF COUNSEL Download | |
| Jan 17, 2019 | 57 | Petitioners' Updated Mandatory Notices Download | |
| Jan 16, 2019 | 56 | Patent Owner Horizon Power of Attorney Download | |
| Jan 16, 2019 | 55 | Amended Power of Attorney Download | |
| Jan 16, 2019 | 54 | Updated Mandatory Notices Download | |
| Jan 4, 2019 | 53 | Updated Exhibit List Download | |
| Jan 4, 2019 | 1051 | Sale Order Download | |
| Jan 4, 2019 | 1052 | Stalking Horse Agreement Download | |
| Sep 4, 2018 | 2072 | Patent Owner Pozen Inc. Exhibit 2072 - Bankruptcy Petition Download | |
| Sep 4, 2018 | 52 | Patent Owners Exhibit List Download | |
| Sep 4, 2018 | 2072 | Patent Owner Pozen Inc. Exhibit 2072 - Bankruptcy Petition Download | |
| Aug 31, 2018 | 51 | Order - Conduct of the Proceeding Suspending Deadlines Due to Suggestion of Bankruptcy Download | |
| Aug 31, 2018 | 3002 | Ex. 3002 Download | |
| Aug 28, 2018 | 50 | Patent Owner Pozen Inc.'s Suggestion of Bankruptcy Download | |
| Aug 22, 2018 | 49 | Order Granting Petitioner Mylan Pharmaceuticals Inc.'s Motion for Pro Hac Vice Admission of Autumn N. Nero Download | |
| Aug 21, 2018 | 48 | Petitioners' Notice of Deposition of David A. Johnson, M.D. Download | |
| Aug 14, 2018 | 47 | Trial Instituted Document Granting Petitioner's Motion for Joinder and Instituting Inter Partes Review Download | |
| Aug 8, 2018 | 46 | Petitioner's Notice of Deposition of David R. Taft, Ph.D. Download | |
| Jun 22, 2018 | 44 | Joint Notice of Stipulation to Adjust Schedule Download | |
| Jun 22, 2018 | 45 | Patent Owner's Exhibit List Download | |
| Jun 22, 2018 | 2070 | Patent Owner Exhibit 2070 Download | |
| Jun 22, 2018 | 2071 | Patent Owner Exhibit 2071 Download | |
| Jun 18, 2018 | 42 | Motion for pro hac vice admission of Autumn N. Nero Download | |
| Jun 18, 2018 | 41 | Updated List of Petitioner's Exhibits Download | |
| Jun 18, 2018 | 43 | Petitioner's Updated Mandatory Notices Download | |
| Jun 18, 2018 | 1050 | Declaration of Autumn N. Nero Download | |
| Jun 11, 2018 | 39 | Granting Petitioner Mylan Pharmaceuticals Inc. Motion for Pro Hac Vice Admission of Bryan D. Beel and Robert D. Swanson 37 C.F.R. sec 42.10 Download | |
| Jun 11, 2018 | 40 | Granting Patent Owner Horizon Pharma USA, Inc. Motion for Ellen Scordino to Appear Pro Hac Vice 37 C.F.R. sec 42.10 Download | |
| Jun 8, 2018 | 38 | Petitioner's Objections to Patent Owners' Evidence Download | |
| Jun 1, 2018 | 2064 | F.L. Lanza, A guideline for the treatment and prevention of NSAID-induced Ulcers, Am. J. Gastroenterol., 93(11):2037¿¿¿2046 (1998) Download | |
| Jun 1, 2018 | 2063 | J.L. Wallace et al., Gastrointestinal-sparing anti-inflammatory drugs: the development of nitric oxide-releasing NSAIDs, Drug Dev Res 42:144-149 (1997) Download | |
| Jun 1, 2018 | 2066 | J.L. Goldstein et al., Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone, Aliment Pharmacol. Ther., 32:401-413 (2010) Download | |
| Jun 1, 2018 | 2062 | FDA Public Health Advisory, April 7, 2005, available at http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm150314.htm (last accessed March 23, 2015)). Download | |
| Jun 1, 2018 | 2068 | IPR2017-01995 Corrected Declaration of Bryan D. Beel in Support of Petitioner¿¿¿s Evidence, June 1, 2018 Download | |
| Jun 1, 2018 | 2069 | M. Hassan-Alin et al., Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects, Eur. J. Clin. Pharmacol., 56:665-670 (2000) Download | |
| Jun 1, 2018 | 2061 | Wolfe et al., Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy, J. Rheumatol. 29(3):467-473 (2002) Download | |
| Jun 1, 2018 | 2065 | J.L. Goldstein et al., Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications, Clin. Gastroenterol. & Hepatology, 4:1337-1345 (2006) Download | |
| Jun 1, 2018 | 2038 | Prilosec Label Download | |
| Jun 1, 2018 | 2054 | H. Koop, Review article: metabolic consequences of long-term inhibition of acid secretion by omeprazole, Aliment. Pharmacol. Ther. 6:399¿¿¿406 (1992) Download | |
| Jun 1, 2018 | 2046 | G. Singh, Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database, Am. J. Ther., 7:115¿¿¿121 (2000) Download | |
| Jun 1, 2018 | 2056 | D.A. Johnson, Review of esomeprazole in the treatment of acid disorders, Expert Opin. Pharmacother. 4(2):253-264 (2003) Download | |
| Jun 1, 2018 | 2033 | Andersson et al., Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of Omeprazole, CLIN. PHARMACOKINET., 40(6):411-426 (2001) Download | |
| Jun 1, 2018 | 2013 | Cryer, B. and Feldman, M., Effects of Nonsteroidal Anti-inflammatory Drugs on Endogenous Gastrointestinal Prostaglandins and Therapeutic Strategies for Prevention etc., Vol. 152, pp. 1145-1155 (1992) (with publication information) Download | |
| Jun 1, 2018 | 2043 | L. Laine, Nonsteroidal anti-inflammatory drug gastropathy, Gastrointest. Endosc. Clin. North Am., 6(3):489¿¿¿504 (1996) Download | |
| Jun 1, 2018 | 2024 | January 30, 2013 Amendment C and Response to Final Office Action, Application No. 12/553,107 Download | |
| Jun 1, 2018 | 2060 | R.J. Flower, Reviews: The development of COX2 inhibitors, Nature 2:179-191 (2003) Download | |
| Jun 1, 2018 | 2029 | IPR2017-01995, May 24, 2018 Deposition Transcript of Dr. Michael Mayersohn Download | |
| Jun 1, 2018 | 2018 | Oct. 12, 2017 Deposition Testimony of Everardus Orlemans, Ph.D. in the Horizon Pharma, Inc. v. Dr. Reddy¿¿¿s Laboratories, Inc., Case No. 3:15-cv-03324 (D.N.J.) Download | |
| Jun 1, 2018 | 2034 | Tolman et al., The Effects of Oral Doses of Lansoprazole and Omeprazole on Gastric pH, J. CLIN. GASTROENTEROL., 24(2):65-70 (1997) Download | |
| Jun 1, 2018 | 2052 | C.W. Howden, Clinical pharmacology of omeprazole, Clin. Pharmacokinet 20(1):38-49 (1991)). Download | |
| Jun 1, 2018 | 2036 | Leucuta et al., Pharmcokinetics and Metabolic Drug Interactions, CURRENT CLINICAL PHARMACOLOGY, 1:5-20 (2006) Download | |
| Jun 1, 2018 | 2059 | W. Bensen & A. Zizzo, Newer, safer nonsteroidal anti-inflammatory drugs. Rational NSAID selection for arthritis, Can. Fam. Physician 44:101-102, 105-107 (1998) Download | |
| Jun 1, 2018 | 2041 | VIMOVO Prescribing Information Download | |
| Jun 1, 2018 | 2027 | IPR2017-01995, May 25, 2018 Deposition Transcript of David C. Metz Download | |
| Jun 1, 2018 | 2022 | Stollman, N. and Metz, D.C., Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients, J. Critical Care, Vol. 20, pp. 35-45 (2005) Download | |
| Jun 1, 2018 | 2042 | M.M. Wolfe et al., Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs, N. Engl. J. Med., 340(24):1888-1899 (1999) Download | |
| Jun 1, 2018 | 2015 | Jan. 12, 2017 Trial Testimony of John R. Plachetka in the Horizon Pharma, Inc. v. Dr. Reddy¿¿¿s Laboratories, Inc., Case No. 3:11-cv-02317 (D.N.J.) Download | |
| Jun 1, 2018 | 2058 | S.H. Roth, NSAID gastropathy: A new understanding, Arch. Intern. Med. 156:1623¿¿¿1628 (1996) Download | |
| Jun 1, 2018 | 2047 | NIH, National Institute of Diabetes and Digestive and Kidney Diseases, Bleeding in the Digestive Tract, etc. (last accessed March 23, 2015) Download | |
| Jun 1, 2018 | 2044 | F.E. Silverstein et al., Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial, JAMA, 284(10):1247¿¿¿1255 (2000) Download | |
| Jun 1, 2018 | 2025 | Declaration of David R. Taft PH.D. In Support of Patent Owner Response to Petition for Inter Partes Review of U.S. Patent No. 9,220,698 Download | |
| Jun 1, 2018 | 2045 | C. Bombardier et al., Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N. Engl. J. Med., 343(21):1520¿¿¿1528 (2000) Download | |
| Jun 1, 2018 | 2021 | Norman, A. and Hawkey, C.J., What you need to know when you prescribe a proton pump inhibitor, Frontline Gastroenterology, Vol. 2, pp. 199-205 (2011) Download | |
| Jun 1, 2018 | 2037 | Meyer, Interaction of Proton Pump Inhibitors with Cytochromes P450: Consequences for Drug Interactions, YALE J. BIOL. MED., 69:203-209 (1996) Download | |
| Jun 1, 2018 | 2012 | Gabriel, S.E., et al., Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs, Annals of Internal Medicine, Vol. 115, No. 10, pp. 787-796 (1991) (with publication information) Download | |
| Jun 1, 2018 | 2039 | Vanderhoff et al., Proton Pump Inhibitors: An Update, AMERICAN FAMILY PHYSICIAN, 66:273-280 (2002) Download | |
| Jun 1, 2018 | 2053 | J.Q. Huang & R.H. Hunt, Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician, Best Prac. & Res. Clin. Gastroenterol. 15(3):355-370 (2001) Download | |
| Jun 1, 2018 | 2032 | Email string from Tore Lind to Richard Leff, Doug Levine, David Magner, and Mark Sostek, dated May 27, 2006 to May 31, 2006 Download | |
| Jun 1, 2018 | 2035 | Hartmann et al., Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole, ALIMENT PHARMACOL. THER., 10:359-366 (1996) Download | |
| Jun 1, 2018 | 2026 | Declaration of David A. Johnson. M.D. In Support of Patent Owner Response to Petition for Inter Partes Review of U.S. Patent No. 9,220,698 Download | |
| Jun 1, 2018 | 2040 | Arnold, Safety of proton pump inhibitors-an overview, Aliment Pharmacol. Ther., 8(Suppl. 1):65-70 (1994) Download | |
| Jun 1, 2018 | 2049 | N. Hudson et al., Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration, Gastroenterology, 112:1817-1822 (1997) Download | |
| Jun 1, 2018 | 2048 | K.S. Jain, et al., Recent advances in proton pump inhibitors and management of acid-peptic disorders, Bioorganic & Medicinal Chemistry 15:1181-1205 (2007) Download | |
| Jun 1, 2018 | 2055 | Donnellan C., Preston C., Moayyedi P., Sharma N., Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease (Review), The Cochrane Library, Issue 4, at 14 (2004) Download | |
| Jun 1, 2018 | 2051 | L. Olbe et al., Reviews: A Proton-pump inhibitor expedition: The case histories of omeprazole and esomeprazole, Nature 2:132-139 (2003) Download | |
| Jun 1, 2018 | 2028 | Redacted Amended Memorandum Opinion (D.I. 498), Case 3:11-cv-02317-MLC-DEA (D.N.J. July 12, 2017) Download | |
| Jun 1, 2018 | 2057 | Nexium label Download | |
| Jun 1, 2018 | 2023 | Declaration of Michael Mayersohn, Ph.D. in Support of Defendants¿¿¿ Claim Construction Brief filed on April 24, 2014 in Par Pharm., Inc. v. Takeda Pharm. Co., Case No. 5:13-CV-1927 LHK (PSG) Download | |
| Jun 1, 2018 | 2014 | Fries, J.F., et al., Nonsteroidal Anti-Inflammatory Drug-Associated Gastropathy: Incidence and Risk Factor Models, The American Journal of Medicine, Vol. 91, pp. 213-222 (1991) (with publication information) Download | |
| Jun 1, 2018 | 2031 | Oct. 10, 2014 Deposition Testimony of Dr. Mark Sostek in the Horizon Pharma, Inc. v. Dr. Reddy¿¿¿s Laboratories, Inc., Case No. 3:11-cv-02317 (D.N.J.) PROTECTIVE ORDER MATERIAL Download | |
| Jun 1, 2018 | 2019 | Oct. 27, 2017 Deposition Testimony of Mark Sostek, MD in the Horizon Pharma, Inc. v. Dr. Reddy¿¿¿s Laboratories, Inc., Case No. 3:15-cv-03324 (D.N.J.) PROTECTIVE ORDER MATERIAL Download | |
| Jun 1, 2018 | 2017 | PN400-104 Clinical Study Report PROTECTIVE ORDER MATERIAL Download | |
| Jun 1, 2018 | 2016 | Jan. 24, 2018 Deposition Testimony of Dr. John R. Plachetka in the Horizon Pharma, Inc. v. Dr. Reddy¿¿¿s Laboratories, Inc., Case No. 3:15-cv-03324 (D.N.J.) PROTECTIVE ORDER MATERIAL Download | |
| Jun 1, 2018 | 2020 | Oct. 25, 2017 Deposition Testimony of Brian Ault, Ph.D. in the Horizon Pharma, Inc. v. Dr. Reddy¿¿¿s Laboratories, Inc., Case No. 3:15-cv-03324 (D.N.J.) PROTECTIVE ORDER MATERIAL Download | |
| Jun 1, 2018 | 2067 | AstraZeneca/Pozen Collaboration and License Agreement (August 1, 2006) PROTECTIVE ORDER MATERIAL Download | |
| Jun 1, 2018 | 35 | Patent Owner's Exhibit List Download | |
| Jun 1, 2018 | 36 | Download | |
| Jun 1, 2018 | 37 | Download | |
| May 25, 2018 | 34 | Denying Patent Owners Request for Rehearing 37 C.F.R. sec 42.71 Download | |
| May 11, 2018 | 32 | Motion for Ellen Scordino To Appear Pro Hac Vice On Behalf Of Patent Owner Horizon Pharma USA, Inc. Download | |
| May 11, 2018 | 33 | Declaration Of Ellen Scordino In Support Of Motion To Appear Pro Hac Vice On Behalf Of Patent Owner Horizon Pharma USA, Inc. Download | |
| May 11, 2018 | 31 | Patent Owners' Updated Mandatory Notices Download | |
| May 9, 2018 | 30 | Joint Notice of Stipulation to Adjust Schedule Download | |
| Apr 2, 2018 | 27 | Motion for Pro Hac Vice Admission of Bryan Beel Download | |
| Apr 2, 2018 | 28 | Motion for Pro Hac Vice Admission of Robert Swanson Download | |
| Apr 2, 2018 | 29 | Petitioners' Updated Exhibit List Download | |
| Apr 2, 2018 | 1049 | Swanson Declaration Download | |
| Apr 2, 2018 | 1048 | Declaration of Bryan Beel Download | |
| Mar 29, 2018 | 26 | Petitioner's Objections to Patent Owner Evidence Download | |
| Mar 22, 2018 | 25 | Patent Owners' Exhibit List Download | |
| Mar 22, 2018 | 22 | Patent Owners' Objections to Petitioner's Evidence Pursuant to 37 CFR section 42.64(b)(1) Download | |
| Mar 22, 2018 | 23 | Petitioner's Objections to Patent Owner Evidence Download | |
| Mar 22, 2018 | 24 | Patent Owners' Request for Rehearing of the Decision to Institute Pursuant to 37 CFR section 42.71(c) ,d) Download | |
| Mar 22, 2018 | 2010 | Email string from Mylan's counsel, Robert D. Swanson from February 6, 2017 to February 15, 2017 Download | |
| Mar 8, 2018 | 3001 | Ex. 3001 Download | |
| Mar 8, 2018 | 21 | Order - Granting Patent Owner Horizon Pharma USA, Inc.'s Motion for Pro Hac Vice Admission of Susan Krumplitsch - 37 CFR 42.10 Download | |
| Mar 8, 2018 | 19 | Scheduling Order Download | |
| Mar 8, 2018 | 18 | Trial Instituted Document Download | |
| Mar 8, 2018 | 20 | Order - Granting Patent Owner Horizon Pharma USA, Inc.'s Motion for Pro Hac Vice Admission of Jonathan G. Graves - 37 CFR 42.10 Download | |
| Jan 25, 2018 | 16 | Reply to Patent Owner's Preliminary Response Download | |
| Jan 25, 2018 | 17 | Petitioners' Updated Exhibit List Download | |
| Jan 25, 2018 | 1047 | Stipulation and Order Download | |
| Jan 18, 2018 | 15 | Order Granting Petitioner Request to File a Reply Download | |
| Jan 12, 2018 | 2008 | Declaration of Jonathan G.Graves in Support of Motion to Appear Pro Hac Vice on Behalf of Patent Owner Horizon Pharma USA, Inc. Download | |
| Jan 12, 2018 | 12 | Motion for Jonathan G. Graves to Appear Pro Hac Vice on Behalf of Patent Owner Horizon Pharma USA, Inc. Download | |
| Jan 12, 2018 | 13 | Motion for Susan Krumplitsch to Appear Pro Hac Vice on Behalf of Patent Owner Horizon Pharma USA, Inc. Download | |
| Jan 12, 2018 | 14 | Patent Owner's Exhibit List Download | |
| Jan 12, 2018 | 2009 | Declaration of Susan Krumplitsch in Support of Motion to Appear Pro Hac Vice on Behalf of Patent Owner Horizon Pharma USA, Inc. Download | |
| Dec 12, 2017 | 2006 | Exhibit 2006 Download | |
| Dec 12, 2017 | 2003 | Exhibit 2003 Download | |
| Dec 12, 2017 | 2005 | Exhibit 2005 Download | |
| Dec 12, 2017 | 10 | Patent Owner Preliminary Response Download | |
| Dec 12, 2017 | 2007 | Exhibit 2007 Download | |
| Dec 12, 2017 | 2004 | Exhibit 2004 Download | |
| Dec 12, 2017 | 11 | Patent Owner's Exhibit List Download | |
| Dec 12, 2017 | 2001 | Exhibit 2001 Download | |
| Dec 12, 2017 | 2002 | Exhibit 2002 Download | |
| Sep 14, 2017 | 8 | Patent Owner's Mandatory Notices Download | |
| Sep 14, 2017 | 6 | Patent Owner's Mandatory Notices Download | |
| Sep 14, 2017 | 9 | Power of Attorney Download | |
| Sep 14, 2017 | 7 | Power of Attorney Download | |
| Sep 13, 2017 | 3 | Notice of Accord Filing Date Download | |
| Aug 24, 2017 | 1038 | 2012-05-08 Response Download | |
| Aug 24, 2017 | 1014 | Wolfe 2000 Download | |
| Aug 24, 2017 | 1003 | Mayersohn Declaration Download | |
| Aug 24, 2017 | 1022 | Rowland and Tozer 1995 Download | |
| Aug 24, 2017 | 1039 | 2014-12-16 Response Download | |
| Aug 24, 2017 | 1009 | 2007 EC Naprosyn Label Download | |
| Aug 24, 2017 | 1007 | '192 Patent Download | |
| Aug 24, 2017 | 1026 | Mayersohn, Modern Pharmaceutics Download | |
| Aug 24, 2017 | 2 | Petition for Inter Partes Review Download | |
| Aug 24, 2017 | 1010 | Zegerid 2004 Label Download | |
| Aug 24, 2017 | 1042 | Goldlust 2004 Download | |
| Aug 24, 2017 | 1008 | EC Naprosyn Approval Download | |
| Aug 24, 2017 | 1025 | '504 Patent Download | |
| Aug 24, 2017 | 1017 | Khosravan Download | |
| Aug 24, 2017 | 1028 | Lind 2000 Download | |
| Aug 24, 2017 | 1 | Power of Attorney Download | |
| Aug 24, 2017 | 1011 | Goldstein 2008 Download | |
| Aug 24, 2017 | 1027 | Howden 1991 Download | |
| Aug 24, 2017 | 1029 | Regardh Download | |
| Aug 24, 2017 | 1002 | Metz Declaration Download | |
| Aug 24, 2017 | 1034 | 2012-01-05 Office Action Download | |
| Aug 24, 2017 | 1006 | Howden 2005 Download | |
| Aug 24, 2017 | 1021 | Harrison's 2005 Download | |
| Aug 24, 2017 | 1035 | 2012-07-30 Office Action Download | |
| Aug 24, 2017 | 1040 | 2015-09-25 Response Download | |
| Aug 24, 2017 | 1020 | 2017 Naprosyn Label Download | |
| Aug 24, 2017 | 1031 | Websters Dictionary (Target) Download | |
| Aug 24, 2017 | 1041 | 2012-10-09 Advisory Action Download | |
| Aug 24, 2017 | 1001 | U.S. Patent No. 9,220,698 Download | |
| Aug 24, 2017 | 1019 | Davies 1997 Download | |
| Aug 24, 2017 | 1004 | '907 Patent Download | |
| Aug 24, 2017 | 1023 | Clissold Download | |
| Aug 24, 2017 | 1013 | 2013-01-30 Response to Office Action Download | |
| Aug 24, 2017 | 1030 | Vimovo 2014 Label Download | |
| Aug 24, 2017 | 1016 | Hassan-Alin Download | |
| Aug 24, 2017 | 1005 | '285 Patent Download | |
| Aug 24, 2017 | 1015 | Bell Download | |
| Aug 24, 2017 | 1018 | Jung Download | |
| Aug 24, 2017 | 1024 | '070 Patent Download | |
| Aug 24, 2017 | 1032 | American Heritage Dictionary (Target) Download | |
| Aug 24, 2017 | 1037 | 2015-03-26 Office Action Download | |
| Aug 24, 2017 | 1036 | 2014-06-16 Office Action Download | |
| Aug 24, 2017 | 1033 | Merriam Webster Dictionary (Target) Download | |
| Aug 24, 2017 | 1012 | Hochberg EULAR 2008 Download |
